-
1
-
-
0037443563
-
Secretory phospholipases A2 activate selective functions in human eosinophils
-
12626587
-
Secretory phospholipases A2 activate selective functions in human eosinophils. M Triggiani F Granata B Balestrieri A Petraroli G Scalia L Del Vecchio G Marone, J Immunol 2003 170 3279 3288 12626587
-
(2003)
J Immunol
, vol.170
, pp. 3279-3288
-
-
Triggiani, M.1
Granata, F.2
Balestrieri, B.3
Petraroli, A.4
Scalia, G.5
Del Vecchio, L.6
Marone, G.7
-
2
-
-
33750952878
-
Activation of human inflammatory cells by secreted phospholipases A2
-
16952481
-
Activation of human inflammatory cells by secreted phospholipases A2. M Triggiani F Granata A Frattini G Marone, Biochim Biophys Acta 2006 1761 1289 1300 16952481
-
(2006)
Biochim Biophys Acta
, vol.1761
, pp. 1289-1300
-
-
Triggiani, M.1
Granata, F.2
Frattini, A.3
Marone, G.4
-
3
-
-
27644566534
-
Secretory phospholipases A2 in inflammatory and allergic diseases: Not just enzymes
-
10.1016/j.jaci.2005.08.011. 16275367
-
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. M Triggiani F Granata G Giannattasio G Marone, J Allergy Clin Immunol 2005 116 1000 1006 10.1016/j.jaci.2005.08.011 16275367
-
(2005)
J Allergy Clin Immunol
, vol.116
, pp. 1000-1006
-
-
Triggiani, M.1
Granata, F.2
Giannattasio, G.3
Marone, G.4
-
4
-
-
0029662071
-
Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients
-
8823686
-
Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. MK Lin V Farewell P Vadas AA Bookman EC Keystone W Pruzanski, J Rheumatol 1996 23 1162 1166 8823686
-
(1996)
J Rheumatol
, vol.23
, pp. 1162-1166
-
-
Lin, M.K.1
Farewell, V.2
Vadas, P.3
Bookman, A.A.4
Keystone, E.C.5
Pruzanski, W.6
-
5
-
-
8744226866
-
Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor
-
10.1089/neu.2004.21.1683. 15684658
-
Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor. TJ Cunningham N Souayah B Jameson J Mitchell L Yao, J Neurotrauma 2004 21 1683 1691 10.1089/neu.2004.21.1683 15684658
-
(2004)
J Neurotrauma
, vol.21
, pp. 1683-1691
-
-
Cunningham, T.J.1
Souayah, N.2
Jameson, B.3
Mitchell, J.4
Yao, L.5
-
6
-
-
33750047832
-
Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis
-
16965627. 10.1186/1742-2094-3-26
-
Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. TJ Cunningham L Yao M Oetinger L Cort EP Blankenhorn JI Greenstein, J Neuroinflammation 2006 3 26 16965627 10.1186/1742-2094-3-26
-
(2006)
J Neuroinflammation
, vol.3
, pp. 26
-
-
Cunningham, T.J.1
Yao, L.2
Oetinger, M.3
Cort, L.4
Blankenhorn, E.P.5
Greenstein, J.I.6
-
7
-
-
17944399890
-
Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris
-
10.1016/S0002-9149(00)01069-9. 11018189
-
Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris. K Kugiyama Y Ota S Sugiyama H Kawano H Doi H Soejima S Miyamoto H Ogawa K Takazoe H Yasue, Am J Cardiol 2000 86 718 722 10.1016/S0002-9149(00)01069-9 11018189
-
(2000)
Am J Cardiol
, vol.86
, pp. 718-722
-
-
Kugiyama, K.1
Ota, Y.2
Sugiyama, S.3
Kawano, H.4
Doi, H.5
Soejima, H.6
Miyamoto, S.7
Ogawa, H.8
Takazoe, K.9
Yasue, H.10
-
8
-
-
0032941386
-
Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2
-
10323781
-
Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. B Ivandic LW Castellani XP Wang JH Qiao M Mehrabian M Navab AM Fogelman DS Grass ME Swanson MC de Beer, Arterioscler Thromb Vasc Biol 1999 19 1284 1290 10323781
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 1284-1290
-
-
Ivandic, B.1
Castellani, L.W.2
Wang, X.P.3
Qiao, J.H.4
Mehrabian, M.5
Navab, M.6
Fogelman, A.M.7
Grass, D.S.8
Swanson, M.E.9
De Beer, M.C.10
-
10
-
-
0037131329
-
Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: Implications for the inflammatory response in atherogenesis
-
10.1161/01.RES.0000038341.34243.64. 12386144
-
Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: implications for the inflammatory response in atherogenesis. L Fuentes M Hernandez FJ Fernandez-Aviles MS Crespo ML Nieto, Circ Res 2002 91 681 688 10.1161/01.RES.0000038341.34243.64 12386144
-
(2002)
Circ Res
, vol.91
, pp. 681-688
-
-
Fuentes, L.1
Hernandez, M.2
Fernandez-Aviles, F.J.3
Crespo, M.S.4
Nieto, M.L.5
-
11
-
-
0029033619
-
Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells
-
7540278
-
Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. M Jaattela M Benedict M Tewari JA Shayman VM Dixit, Oncogene 1995 10 2297 2305 7540278
-
(1995)
Oncogene
, vol.10
, pp. 2297-2305
-
-
Jaattela, M.1
Benedict, M.2
Tewari, M.3
Shayman, J.A.4
Dixit, V.M.5
-
12
-
-
0028802503
-
Mediators of injury in neurotrauma: Intracellular signal transduction and gene expression
-
8594208
-
Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. NG Bazan EB Rodriguez de Turco G Allan, J Neurotrauma 1995 12 791 814 8594208
-
(1995)
J Neurotrauma
, vol.12
, pp. 791-814
-
-
Bazan, N.G.1
Rodriguez De Turco, E.B.2
Allan, G.3
-
13
-
-
0036669210
-
Phospholipase A2 enzymes
-
10.1016/S0090-6980(02)00020-5
-
Phospholipase A2 enzymes. I Kudo M Murakami, Prostaglandins Other Lipid Mediat 2002 68-69 3 58 10.1016/S0090-6980(02)00020-5
-
(2002)
Prostaglandins Other Lipid Mediat
, vol.68-69
, pp. 3-58
-
-
Kudo, I.1
Murakami, M.2
-
15
-
-
55649088739
-
128 Decreased lysophosphatidylcholine levels are associated with sepsis compared to uninfected inflammation prior to onset of sepsis
-
10.1016/j.jss.2006.12.141
-
128 Decreased lysophosphatidylcholine levels are associated with sepsis compared to uninfected inflammation prior to onset of sepsis. E Lissauer B Johnson S Shi T Gentle M Scalea, Journal of Surgical Research 2007 137 206 206 10.1016/j.jss.2006.12.141
-
(2007)
Journal of Surgical Research
, vol.137
, pp. 206-206
-
-
Lissauer, E.1
Johnson, B.2
Shi, S.3
Gentle, T.4
Scalea, M.5
-
16
-
-
0142074218
-
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
-
10.1194/jlr.M200401-JLR200
-
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. W Drobnik, The Journal of Lipid Research 2003 44 754 761 10.1194/jlr.M200401-JLR200
-
(2003)
The Journal of Lipid Research
, vol.44
, pp. 754-761
-
-
Drobnik, W.1
-
17
-
-
33746048017
-
Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of Gram-negative and Gram-positive shock
-
16751791. 10.1038/sj.bjp.0706788
-
Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of Gram-negative and Gram-positive shock. O Murch M Collin B Sepodes SJ Foster H Mota-Filipe C Thiemermann, British Journal of Pharmacology 2006 148 769 777 16751791 10.1038/sj.bjp.0706788
-
(2006)
British Journal of Pharmacology
, vol.148
, pp. 769-777
-
-
Murch, O.1
Collin, M.2
Sepodes, B.3
Foster, S.J.4
Mota-Filipe, H.5
Thiemermann, C.6
-
18
-
-
11144354207
-
Therapeutic effects of lysophosphatidylcholine in experimental sepsis
-
10.1038/nm989. 14716308
-
Therapeutic effects of lysophosphatidylcholine in experimental sepsis. JJ Yan JS Jung JE Lee J Lee SO Huh HS Kim KC Jung JY Cho JS Nam HW Suh, Nat Med 2004 10 161 167 10.1038/nm989 14716308
-
(2004)
Nat Med
, vol.10
, pp. 161-167
-
-
Yan, J.J.1
Jung, J.S.2
Lee, J.E.3
Lee, J.4
Huh, S.O.5
Kim, H.S.6
Jung, K.C.7
Cho, J.Y.8
Nam, J.S.9
Suh, H.W.10
-
19
-
-
21744439466
-
Suppression of HMGB 1 release by stearoyl lysophosphatidylcholine: An additional mechanism for its therapeutic effects in experimental sepsis
-
10.1194/jlr.C400018-JLR200
-
Suppression of HMGB 1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis. G Chen, The Journal of Lipid Research 2005 46 623 627 10.1194/jlr.C400018-JLR200
-
(2005)
The Journal of Lipid Research
, vol.46
, pp. 623-627
-
-
Chen, G.1
-
20
-
-
21744439466
-
Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis
-
10.1194/jlr.C400018-JLR200. 15687351
-
Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. G Chen J Li X Qiang CJ Czura M Ochani K Ochani L Ulloa H Yang KJ Tracey P Wang, J Lipid Res 2005 46 623 627 10.1194/jlr.C400018-JLR200 15687351
-
(2005)
J Lipid Res
, vol.46
, pp. 623-627
-
-
Chen, G.1
Li, J.2
Qiang, X.3
Czura, C.J.4
Ochani, M.5
Ochani, K.6
Ulloa, L.7
Yang, H.8
Tracey, K.J.9
Wang, P.10
-
21
-
-
0036303682
-
A Potent Protective Role of Lysophospholipids Against Global Cerebral Ischemia and Glutamate Excitotoxicity in Neuronal Cultures
-
10.1097/00004647-200207000-00007. 12142567
-
A Potent Protective Role of Lysophospholipids Against Global Cerebral Ischemia and Glutamate Excitotoxicity in Neuronal Cultures. N Blondeau I Lauritzen C Widmann M Lazdunski C Heurteaux, J Cereb Blood Flow Metab 2002 22 821 834 10.1097/00004647-200207000-00007 12142567
-
(2002)
J Cereb Blood Flow Metab
, vol.22
, pp. 821-834
-
-
Blondeau, N.1
Lauritzen, I.2
Widmann, C.3
Lazdunski, M.4
Heurteaux, C.5
-
22
-
-
0035041072
-
An update on inhibitors of human 14 kDa Type II s-PLA2 in development
-
10.2174/1381612013398275. 11311112
-
An update on inhibitors of human 14 kDa Type II s-PLA2 in development. DM Springer, Curr Pharm Des 2001 7 181 198 10.2174/1381612013398275 11311112
-
(2001)
Curr Pharm des
, vol.7
, pp. 181-198
-
-
Springer, D.M.1
-
23
-
-
33750043500
-
Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9
-
16965626. 10.1186/1742-2094-3-25
-
Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9. TJ Cunningham J Maciejewski L Yao, J Neuroinflammation 2006 3 25 16965626 10.1186/1742-2094-3-25
-
(2006)
J Neuroinflammation
, vol.3
, pp. 25
-
-
Cunningham, T.J.1
MacIejewski, J.2
Yao, L.3
-
24
-
-
0344876134
-
Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation
-
10.1002/glia.10296. 14603468
-
Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation. F Pinto T Brenner P Dan M Krimsky S Yedgar, Glia 2003 44 275 282 10.1002/glia.10296 14603468
-
(2003)
Glia
, vol.44
, pp. 275-282
-
-
Pinto, F.1
Brenner, T.2
Dan, P.3
Krimsky, M.4
Yedgar, S.5
-
25
-
-
33845995114
-
Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction
-
10.1074/jbc.M607975200. 17008322
-
Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. M Ohtsuki Y Taketomi S Arata S Masuda Y Ishikawa T Ishii Y Takanezawa J Aoki H Arai K Yamamoto, J Biol Chem 2006 281 36420 36433 10.1074/jbc.M607975200 17008322
-
(2006)
J Biol Chem
, vol.281
, pp. 36420-36433
-
-
Ohtsuki, M.1
Taketomi, Y.2
Arata, S.3
Masuda, S.4
Ishikawa, Y.5
Ishii, T.6
Takanezawa, Y.7
Aoki, J.8
Arai, H.9
Yamamoto, K.10
-
26
-
-
0036061703
-
Human Secretory Phospholipase A2 Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice
-
10.1161/01.ATV.0000023228.90866.29. 12117740
-
Human Secretory Phospholipase A2 Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice. UJF Tietge C Maugeais S Lund-Katz D Grass FC deBeer DJ Rader, Arterioscler Thromb Vasc Biol 2002 22 7 1213 1218 10.1161/01.ATV.0000023228.90866.29 12117740
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, Issue.7
, pp. 1213-1218
-
-
Tietge, U.J.F.1
Maugeais, C.2
Lund-Katz, S.3
Grass, D.4
Debeer, F.C.5
Rader, D.J.6
-
27
-
-
0022404771
-
Analysis of progress curves for a highly concentrated michaelian enzyme in the presence or absence of product inhibition
-
4062893
-
Analysis of progress curves for a highly concentrated michaelian enzyme in the presence or absence of product inhibition. N Kellershohn M Laurent, Biochem J 1985 231 65 74 4062893
-
(1985)
Biochem J
, vol.231
, pp. 65-74
-
-
Kellershohn, N.1
Laurent, M.2
-
28
-
-
11144354714
-
Potent Anti-tumor Effects of an Active Site Mutant of Human Manganese-Superoxide Dismutase: EVOLUTIONARY CONSERVATION of PRODUCT INHIBITION
-
10.1074/jbc.M310623200. 14688256
-
Potent Anti-tumor Effects of an Active Site Mutant of Human Manganese-Superoxide Dismutase: EVOLUTIONARY CONSERVATION OF PRODUCT INHIBITION. CA Davis AS Hearn B Fletcher J Bickford JE Garcia V Leveque JA Melendez DN Silverman J Zucali A Agarwal, Journal of Biological Chemistry 2004 279 12769 10.1074/jbc.M310623200 14688256
-
(2004)
Journal of Biological Chemistry
, vol.279
, pp. 12769
-
-
Davis, C.A.1
Hearn, A.S.2
Fletcher, B.3
Bickford, J.4
Garcia, J.E.5
Leveque, V.6
Melendez, J.A.7
Silverman, D.N.8
Zucali, J.9
Agarwal, A.10
-
29
-
-
36048944667
-
Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation
-
10.1152/ajpcell.00224.2007. 17881609
-
Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation. AJ Pope L Druhan JE Guzman SP Forbes V Murugesan D Lu Y Xia LG Chicoine NL Parinandi AJ Cardounel, American Journal of Physiology- Cell Physiology 2007 293 C1679 10.1152/ajpcell.00224.2007 17881609
-
(2007)
American Journal of Physiology- Cell Physiology
, vol.293
, pp. 1679
-
-
Pope, A.J.1
Druhan, L.2
Guzman, J.E.3
Forbes, S.P.4
Murugesan, V.5
Lu, D.6
Xia, Y.7
Chicoine, L.G.8
Parinandi, N.L.9
Cardounel, A.J.10
-
30
-
-
0019888164
-
The kinetics of the phospholipase A2-catalyzed hydrolysis of Egg phosphatidylcholine in unilamellar vesicles. Product inhibition and its relief by serum albumin
-
7240204
-
The kinetics of the phospholipase A2-catalyzed hydrolysis of Egg phosphatidylcholine in unilamellar vesicles. Product inhibition and its relief by serum albumin. JP Kupferberg S Yokoyama FJ Kezdy, Journal of Biological Chemistry 1981 256 6274 6281 7240204
-
(1981)
Journal of Biological Chemistry
, vol.256
, pp. 6274-6281
-
-
Kupferberg, J.P.1
Yokoyama, S.2
Kezdy, F.J.3
-
31
-
-
0022182544
-
Activation, aggregation, and product inhibition of cobra venom phospholipase A2 and comparison with other phospholipases
-
4030786
-
Activation, aggregation, and product inhibition of cobra venom phospholipase A2 and comparison with other phospholipases. A Pluckthun EA Dennis, Journal of Biological Chemistry 1985 260 11099 11106 4030786
-
(1985)
Journal of Biological Chemistry
, vol.260
, pp. 11099-11106
-
-
Pluckthun, A.1
Dennis, E.A.2
-
32
-
-
70449158340
-
A Simple Method for the Isolation and Purification of Total Lipides from Animal Tissues
-
13428781
-
A Simple Method for the Isolation and Purification of Total Lipides From Animal Tissues. J Folch M Lees GS Stanley, Journal of Biological Chemistry 1957 226 497 509 13428781
-
(1957)
Journal of Biological Chemistry
, vol.226
, pp. 497-509
-
-
Folch, J.1
Lees, M.2
Stanley, G.S.3
-
33
-
-
0019304939
-
Colorimetric determination of phospholipids with ammonium ferrothiocyanate
-
10.1016/0003-2697(80)90269-9. 6892980
-
Colorimetric determination of phospholipids with ammonium ferrothiocyanate. JCM Stewart, Anal Biochem 1980 104 10 14 10.1016/0003-2697(80) 90269-9 6892980
-
(1980)
Anal Biochem
, vol.104
, pp. 10-14
-
-
Stewart, J.C.M.1
-
34
-
-
0033957808
-
Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography
-
10627512
-
Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography. K Yokoyama F Shimizu M Setaka, J Lipid Res 2000 41 1 142 147 10627512
-
(2000)
J Lipid Res
, vol.41
, Issue.1
, pp. 142-147
-
-
Yokoyama, K.1
Shimizu, F.2
Setaka, M.3
-
35
-
-
0021589194
-
Comparison of two copper reagents for detection of saturated and unsaturated neutral lipids by charring-densitometry
-
10.1080/01483918408067046
-
Comparison of two copper reagents for detection of saturated and unsaturated neutral lipids by charring-densitometry. CB Baron RF Coburn, J Liqu Chromatogr 1984 7 2793 2801 10.1080/01483918408067046
-
(1984)
J Liqu Chromatogr
, vol.7
, pp. 2793-2801
-
-
Baron, C.B.1
Coburn, R.F.2
-
36
-
-
34147152663
-
Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic
-
10.1194/jlr.M600413-JLR200
-
Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic. R Bartz WH Li B Venables JK Zehmer MR Roth R Welti RGW Anderson P Liu KD Chapman, The Journal of Lipid Research 2007 48 837 10.1194/jlr.M600413-JLR200
-
(2007)
The Journal of Lipid Research
, vol.48
, pp. 837
-
-
Bartz, R.1
Li, W.H.2
Venables, B.3
Zehmer, J.K.4
Roth, M.R.5
Welti, R.6
Anderson, R.G.W.7
Liu, P.8
Chapman, K.D.9
-
37
-
-
0024593571
-
A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin
-
10.1016/0003-2697(89)90022-5. 2742139
-
A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. F Radvanyi L Jordan F Russo-Marie C Bon, Anal Biochem 1989 177 103 109 10.1016/0003-2697(89) 90022-5 2742139
-
(1989)
Anal Biochem
, vol.177
, pp. 103-109
-
-
Radvanyi, F.1
Jordan, L.2
Russo-Marie, F.3
Bon, C.4
-
39
-
-
0033983832
-
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat
-
10600639. 10.1042/0264-6021:3450061
-
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. M Croset N Brossard A Polette M Lagarde, Biochemical Journal 2000 345 61 10600639 10.1042/0264-6021:3450061
-
(2000)
Biochemical Journal
, vol.345
, pp. 61
-
-
Croset, M.1
Brossard, N.2
Polette, A.3
Lagarde, M.4
-
40
-
-
0021783983
-
Reduction in plasma cholesterol and increase in biliary cholesterol by a diet rich in n-3 fatty acids in the rat
-
4031646
-
Reduction in plasma cholesterol and increase in biliary cholesterol by a diet rich in n-3 fatty acids in the rat. S Balasubramaniam LA Simons S Chang JB Hickie, J Lipid Res 1985 26 6 684 689 4031646
-
(1985)
J Lipid Res
, vol.26
, Issue.6
, pp. 684-689
-
-
Balasubramaniam, S.1
Simons, L.A.2
Chang, S.3
Hickie, J.B.4
-
41
-
-
0014982515
-
Exchange of phospholipid classes between liver microsomes and plasma: Comparison of rat, rabbit, and guinea pig
-
5542703
-
Exchange of phospholipid classes between liver microsomes and plasma: comparison of rat, rabbit, and guinea pig. DB Zilversmit, J Lipid Res 1971 12 36 42 5542703
-
(1971)
J Lipid Res
, vol.12
, pp. 36-42
-
-
Zilversmit, D.B.1
-
42
-
-
0030976523
-
Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine (lysoPC) in ovarian cancer patients
-
10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4
-
Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine (lysoPC) in ovarian cancer patients. M Okita DC Gaudette GB Mills BJ Holub, International Journal of Cancer 1997 71 31 34 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4
-
(1997)
International Journal of Cancer
, vol.71
, pp. 31-34
-
-
Okita, M.1
Gaudette, D.C.2
Mills, G.B.3
Holub, B.J.4
-
43
-
-
0013809039
-
Transport of lysolecithin by albumin in human and rat plasma
-
5865378
-
Transport of lysolecithin by albumin in human and rat plasma. S Switzer HA Eder, J Lipid Res 1965 6 4 506 511 5865378
-
(1965)
J Lipid Res
, vol.6
, Issue.4
, pp. 506-511
-
-
Switzer, S.1
Eder, H.A.2
-
44
-
-
0026596571
-
Bromcresol green assay is nonspecific for rat plasma albumin
-
1733318
-
Bromcresol green assay is nonspecific for rat plasma albumin. BJ Barber VL Stanhope, Am J Physiol 1992 262 1 Pt 2 H299 H302 1733318
-
(1992)
Am J Physiol
, vol.262
, Issue.1 PART 2
-
-
Barber, B.J.1
Stanhope, V.L.2
-
45
-
-
0038384015
-
Acylation of lysophosphatidylcholine plays a key role in the response of monocytes to lipopolysaccharide
-
10.1046/j.1432-1033.2003.03649.x. 12823548
-
Acylation of lysophosphatidylcholine plays a key role in the response of monocytes to lipopolysaccharide. B Schmid MJ Finnen JL Harwood SK Jackson, Eur J Biochem 2003 270 2782 2788 10.1046/j.1432-1033.2003.03649.x 12823548
-
(2003)
Eur J Biochem
, vol.270
, pp. 2782-2788
-
-
Schmid, B.1
Finnen, M.J.2
Harwood, J.L.3
Jackson, S.K.4
-
46
-
-
23944471373
-
Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2
-
16122976
-
Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. W Pruzanski L Lambeau M Lazdunsky W Cho J Kopilov A Kuksis, Biochim Biophys Acta 2005 1736 1 38 50 16122976
-
(2005)
Biochim Biophys Acta
, vol.1736
, Issue.1
, pp. 38-50
-
-
Pruzanski, W.1
Lambeau, L.2
Lazdunsky, M.3
Cho, W.4
Kopilov, J.5
Kuksis, A.6
-
48
-
-
13444291406
-
Paradigm shift in NMDA receptor antagonist drug development: Molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders
-
15665416
-
Paradigm shift in NMDA receptor antagonist drug development: Molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. SA Lipton, J Alzheimers Dis 2004 6 6 Suppl S61 S74 15665416
-
(2004)
J Alzheimers Dis
, vol.6
, Issue.6 SUPPL.
-
-
Lipton, S.A.1
-
49
-
-
0029981211
-
Enzyme Inhibition in Open Systems
-
10.1074/jbc.271.10.5347. 8621387
-
Enzyme Inhibition in Open Systems. AM Westley J Westley, Journal of Biological Chemistry 1996 271 5347 10.1074/jbc.271.10.5347 8621387
-
(1996)
Journal of Biological Chemistry
, vol.271
, pp. 5347
-
-
Westley, A.M.1
Westley, J.2
-
50
-
-
0025724884
-
Interfacial catalysis by phospholipase A2: Determination of the interfacial kinetic rate constants
-
10.1021/bi00243a034. 1854737
-
Interfacial catalysis by phospholipase A2: determination of the interfacial kinetic rate constants. OG Berg BZ Yu J Rogers MK Jain, Biochemistry 1991 30 7283 7297 10.1021/bi00243a034 1854737
-
(1991)
Biochemistry
, vol.30
, pp. 7283-7297
-
-
Berg, O.G.1
Yu, B.Z.2
Rogers, J.3
Jain, M.K.4
-
51
-
-
0032948306
-
Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism
-
10337026. 10.1046/j.1365-2249.1999.00871.x
-
Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. YH Huang L Schafer-Elinder R Wu HE Claesson J Frostegard, Clin Exp Immunol 1999 116 326 331 10337026 10.1046/j.1365-2249.1999.00871.x
-
(1999)
Clin Exp Immunol
, vol.116
, pp. 326-331
-
-
Huang, Y.H.1
Schafer-Elinder, L.2
Wu, R.3
Claesson, H.E.4
Frostegard, J.5
-
52
-
-
17144424304
-
Phospholipid mediators in the vessel wall: Involvement in atherosclerosis
-
10.1097/00075197-200503000-00004
-
Phospholipid mediators in the vessel wall: involvement in atherosclerosis. E Ninio, Current Opinion in Clinical Nutrition and Metabolic Care 2005 8 123 10.1097/00075197-200503000-00004
-
(2005)
Current Opinion in Clinical Nutrition and Metabolic Care
, vol.8
, pp. 123
-
-
Ninio, E.1
-
55
-
-
0029051953
-
Arachidonic acid and lysophosphatidylcholine modulate excitatory transmitter amino acid release from the rat cerebral cortex
-
10.1016/0304-3940(95)11672-J. 7478165
-
Arachidonic acid and lysophosphatidylcholine modulate excitatory transmitter amino acid release from the rat cerebral cortex. MH O'Regan LM Perkins JW Phillis, Neuroscience Letters 1995 193 85 88 10.1016/0304-3940(95) 11672-J 7478165
-
(1995)
Neuroscience Letters
, vol.193
, pp. 85-88
-
-
O'Regan, M.H.1
Perkins, L.M.2
Phillis, J.W.3
-
56
-
-
0026725763
-
Protein kinase C, calcium and phospholipid degradation
-
10.1016/0968-0004(92)90011-W. 1455509
-
Protein kinase C, calcium and phospholipid degradation. Y Asaoka S Nakamura K Yoshida Y Nishizuka, Trends Biochem Sci 1992 17 414 417 10.1016/0968-0004(92)90011-W 1455509
-
(1992)
Trends Biochem Sci
, vol.17
, pp. 414-417
-
-
Asaoka, Y.1
Nakamura, S.2
Yoshida, K.3
Nishizuka, Y.4
-
58
-
-
33846457428
-
Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding
-
10.1016/j.prostaglandins.2006.10.006
-
Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding. YL Kim YJ Im NC Ha DS Im, Prostaglandins and Other Lipid Mediators 2007 83 130 138 10.1016/j.prostaglandins.2006.10.006
-
(2007)
Prostaglandins and Other Lipid Mediators
, vol.83
, pp. 130-138
-
-
Kim, Y.L.1
Im, Y.J.2
Ha, N.C.3
Im, D.S.4
-
59
-
-
0015810189
-
Lysolecithin binding to human and squirrel monkey plasma and tissue components
-
4127872
-
Lysolecithin binding to human and squirrel monkey plasma and tissue components. OW Portman DR Illingworth, Biochim Biophys Acta 1973 326 34 42 4127872
-
(1973)
Biochim Biophys Acta
, vol.326
, pp. 34-42
-
-
Portman, O.W.1
Illingworth, D.R.2
-
61
-
-
0035863175
-
Group X secretory phospholipase A2 induces potent productions of various lipid mediators in mouse peritoneal macrophages
-
Group X secretory phospholipase A2 induces potent productions of various lipid mediators in mouse peritoneal macrophages. A Saiga Y Morioka T Ono K Nakano Y Ishimoto H Arita K Hanasaki, BBA-Molecular and Cell Biology of Lipids 2001 1530 67 76
-
(2001)
BBA-Molecular and Cell Biology of Lipids
, vol.1530
, pp. 67-76
-
-
Saiga, A.1
Morioka, Y.2
Ono, T.3
Nakano, K.4
Ishimoto, Y.5
Arita, H.6
Hanasaki, K.7
-
62
-
-
18244380087
-
Dendritic-cell activation by secretory phospholipase A2
-
10.1182/blood-2004-08-3001. 15494434
-
Dendritic-cell activation by secretory phospholipase A2. R Ramoner T Putz H Gander A Rahm G Bartsch C Schaber M Thurnher, Blood 2005 105 3583 3587 10.1182/blood-2004-08-3001 15494434
-
(2005)
Blood
, vol.105
, pp. 3583-3587
-
-
Ramoner, R.1
Putz, T.2
Gander, H.3
Rahm, A.4
Bartsch, G.5
Schaber, C.6
Thurnher, M.7
-
63
-
-
0037452656
-
Sequence similarity in structurally dissimilar proteins
-
10.1016/S0960-9822(03)00070-8
-
Sequence similarity in structurally dissimilar proteins. S Tomiuk K Hofmann, Current Biology 2003 13 124 125 10.1016/S0960-9822(03)00070-8
-
(2003)
Current Biology
, vol.13
, pp. 124-125
-
-
Tomiuk, S.1
Hofmann, K.2
|